NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/26/2023
Back to search
Official data from USPTO
STEM CELLS TRANSLATIONAL MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
06/26/2023
Classification
Registered
Trademark type
Combined
Nice classes
16, 41
Filing date
08/25/2010
Registration date
05/29/2012
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/26/2023
Last transaction
06/26/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/07/2011
First use in commerce
12/07/2011
Drawing code
3
Owner type
99
Owner location
OXFORD, GB
Examiner
TAYLOR, DAVID
Law office
M30
Current location
TMO LAW OFFICE 112
Mark description
The mark consists of cell design with the words "STEM CELLS TRANSLATIONAL MEDICINE".
Holders and representatives
Holders
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
The AlphaMed Company, Inc.
Representatives
Mark Lerner, Esq. DUANE MORRIS LLP
Technical classification
Nice Classes
Class 16Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
[ Medical and scientific journal providing information in the field of improving human health by advancing biological discoveries through research, clinical trials, regulatory approval and the development of best medical practices ]
Class 41
Online medical and scientific journal providing information in the field of improving human health by advancing biological discoveries through research, clinical trials, regulatory approval and the development of best medical practices
Publications
History of USPTO decisions and trademark events.
47 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/26/2023
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
06/26/2023
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
06/26/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/26/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
11/28/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/22/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/22/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/20/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/29/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/03/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/16/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/16/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/16/2018
E815
TEAS SECTION 8 & 15 RECEIVED
02/05/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/29/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/23/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/23/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
05/29/2012
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/25/2012
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
04/24/2012
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/23/2012
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/30/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/30/2012
IUAF
USE AMENDMENT FILED
03/06/2012
EISU
TEAS STATEMENT OF USE RECEIVED
03/06/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/10/2011
EX1G
SOU EXTENSION 1 GRANTED
09/08/2011
EXT1
SOU EXTENSION 1 FILED
09/08/2011
EEXT
SOU TEAS EXTENSION RECEIVED
09/08/2011
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/10/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2011
PUBO
PUBLISHED FOR OPPOSITION
03/15/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/04/2011
ALIE
ASSIGNED TO LIE
02/04/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/15/2010
GNRT
NON-FINAL ACTION E-MAILED
12/15/2010
CNRT
NON-FINAL ACTION WRITTEN
12/15/2010
DOCK
ASSIGNED TO EXAMINER
12/08/2010
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
08/31/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/28/2010
NWAP
NEW APPLICATION ENTERED
08/28/2010
Continuous trademark protection
Get notified about every new filing that threatens STEM CELLS TRANSLATIONAL MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.